BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Vomaris Innovations Release: Breakthrough Microcurrent Technology Product Procellera® Featured in Eight Scientific and Clinical Abstracts at SAWC May 2 - 5


5/1/2013 9:41:15 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CHANDLER, Ariz., May 1, 2013 /PRNewswire/ -- Vomaris Innovations, Inc., a regenerative medical device company specializing in microcurrent field generating technologies for the wound care market, announced that eight scientific and clinical abstracts on its flagship product Procellera® will be presented at the 26th Annual Symposium on Advanced Wound Care (SAWC) May 2 - 5, 2013 at the Denver Convention Center.

Procellera® is the world's first self-contained antimicrobial wound dressing with microbatteries at its surface. Indications for use include partial and full-thickness wounds such as pressure ulcers, venous ulcers, diabetic ulcers, burns, surgical incisions, donor and/or recipient graft sites.

"This robust collection of high-level scientific and clinical research from some of the best institutions around the country marks the achievement of a significant milestone for Procellera®," said Michael P. Nagel, Vomaris President and CEO. "We are thrilled to give the marketplace the evidence-based clinical outcomes needed to support wider use of our breakthrough product."

One of the abstracts - "Improvement of Human Keratinocyte Migration by a Redox Active Bioelectric Dressing" by lead author Dr. Chandan Sen of Ohio State University - was selected along with three other abstracts as finalists in Excellence in Translational Regenerative Science, honoring investigators involved in cutting edge research fostering the development of cell-based and other therapies in wound healing and regenerative medicine toward clinical applicability. Dr. Sen will give a podium presentation at Session G on May 2, from 9:00 - 9:45am.

Two abstracts, "Evaluation of a Bioelectric Dressing as the Next Generation Wound Care Product in the Battlefield" and "Efficacy Testing of a Bioelectric Wound Dressing Against Clinical Wound Isolates" feature collaborative translational and laboratory research from Diagnostic & Translational Research Center, Walter Reed National Military Medical Center, Henry M. Jackson Foundation and the Combat Wound Initiative.

The remaining five abstracts feature a range of clinical research and case studies, including: "A Study to Demonstrate Efficacy of a Bioelectric Wound Care Dressing in Healing of Acute and Chronic Wounds within a Rehab Center Patient Population" and "Management of Traumatic Wounds with a Bioelectric Wound Dressing" from Bethany Health & Rehabilitation Center in Nashville, TN; "An Innovative Bioelectric Approach to Recalcitrant Wounds" and "Clinical Experience with a Bioelectric Wound Dressing as a Primary and Adjunctive Treatment Method" from Jackson-Madison County General Hospital in Jackson, TN; and "Improved Healing Outcomes with a Bioelectric Wound Dressing" from Grant Wound Care & Hyperbaric Services in Columbus, OH.

The SAWC is the largest annual gathering of scientists and clinicians in the wound care field in the United States and is a platform for linking scientists and clinicians to advance wound-healing research.

Procellera® will be showcased at booth #1035 at the SAWC.

About Vomaris Wound Care, Inc.

Vomaris Innovations, Inc., based in Chandler, Arizona, is a leading edge regenerative medical device company specializing in microcurrent field generating technologies for the wound care market. Its product, Procellera®, is the world's first self-contained antimicrobial wound dressing with microbatteries at its surface. Procellera® is a unique device due to its inherent design with microcurrent technology. Procellera® is indicated for over-the-counter (OTC) and professional (Rx) uses. Randomized clinical trials are in process looking at other possible wound healing benefits for the use of Procellera®.

For more information, visit http://www.vomaris.com or call 480.921.4948.

SOURCE Vomaris Innovations, Inc.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES